• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔黏膜下纤维性变的现行治疗方案:更新。

Current protocols in the management of oral submucous fibrosis: An update.

机构信息

Department of Oral and Maxillofacial Surgery, Navodaya Dental College and Hospital, Raichur, Karnataka, India.

Department of Oral and Maxillofacial Surgery, Bapuji Dental College and Hospital, Davangere, Karnataka, India.

出版信息

J Oral Pathol Med. 2017 Jul;46(6):418-423. doi: 10.1111/jop.12583. Epub 2017 May 4.

DOI:10.1111/jop.12583
PMID:28391602
Abstract

Oral submucous fibrosis (OSMF) is a debilitating condition of oral cavity which has significant potential for malignant transformation. In spite of over 20 years of research, the pathogenesis of the condition is still obscure and no single management modality is effective. Many OSMF treatment protocols have been proposed to alleviate the signs and symptoms of the disorder and there is overwhelming evidence that as areca nut is primary cause, stopping its use may have a considerable effect on symptoms rather than reversing pre-existing fibrosis. We present a review of the current protocols for managing OSMF.

摘要

口腔黏膜下纤维化(OSMF)是一种口腔的进行性疾病,具有恶性转化的巨大潜力。尽管已经进行了 20 多年的研究,但该病的发病机制仍不清楚,也没有单一的治疗方法是有效的。已经提出了许多 OSMF 治疗方案来缓解该疾病的症状,并且有大量证据表明槟榔是主要原因,停止使用槟榔可能对症状有很大的影响,而不是逆转已经存在的纤维化。我们对目前治疗 OSMF 的方案进行了综述。

相似文献

1
Current protocols in the management of oral submucous fibrosis: An update.口腔黏膜下纤维性变的现行治疗方案:更新。
J Oral Pathol Med. 2017 Jul;46(6):418-423. doi: 10.1111/jop.12583. Epub 2017 May 4.
2
Oral submucous fibrosis: an overview of the aetiology, pathogenesis, classification, and principles of management.口腔黏膜下纤维化:病因、发病机制、分类及治疗原则概述
Br J Oral Maxillofac Surg. 2013 Oct;51(7):587-93. doi: 10.1016/j.bjoms.2012.08.014. Epub 2012 Oct 26.
3
Oral submucous fibrosis: An update on pathophysiology of malignant transformation.口腔黏膜下纤维性变:恶性转化的病理生理学更新。
J Oral Pathol Med. 2017 Jul;46(6):413-417. doi: 10.1111/jop.12582. Epub 2017 May 6.
4
Management of oral submucous fibrosis: an overview.口腔黏膜下纤维化的管理:综述
Oral Maxillofac Surg. 2010 Sep;14(3):133-42. doi: 10.1007/s10006-010-0209-x.
5
Oral submucous fibrosis: An update on current theories of pathogenesis.口腔黏膜下纤维性变:发病机制的最新理论。
J Oral Pathol Med. 2017 Jul;46(6):406-412. doi: 10.1111/jop.12581. Epub 2017 May 4.
6
Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.口腔黏膜下纤维性变背景下发生的口腔鳞状细胞癌:一种临床病理特征明显不同的疾病。
Head Neck. 2013 Oct;35(10):1404-9. doi: 10.1002/hed.23143. Epub 2012 Sep 13.
7
Oral submucous fibrosis: a premalignant condition in a 14-year-old Indian girl.口腔黏膜下纤维化:一名14岁印度女孩的癌前病变。
BMJ Case Rep. 2013 Dec 12;2013:bcr2013200786. doi: 10.1136/bcr-2013-200786.
8
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.口腔黏膜下纤维性变背景下的口腔鳞状细胞癌是一种具有独特临床病理特征的疾病,其预后较好。
J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28.
9
Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.口腔黏膜下纤维性变:一种当代叙述性综述,提出了一种多专业协作的方法,以实现早期诊断和临床管理。
J Otolaryngol Head Neck Surg. 2020 Jan 8;49(1):3. doi: 10.1186/s40463-020-0399-7.
10
A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维性变恶性转化机制的系统评价
Eur J Cancer Prev. 2020 Sep;29(5):470-473. doi: 10.1097/CEJ.0000000000000575.

引用本文的文献

1
Does Changes in the Muscles Beneath the Submucosal Tissues Necessitate a Novel Strategy in the Medical Management of OSMF: A Systematic Review.黏膜下组织下方肌肉的变化是否需要在口腔黏膜下纤维化的医学管理中采用新策略:一项系统综述。
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):6124-6130. doi: 10.1007/s12070-024-05063-2. Epub 2024 Sep 11.
2
Interventions for managing oral submucous fibrosis.口腔黏膜下纤维性变的处理干预。
Cochrane Database Syst Rev. 2024 Feb 28;2(2):CD007156. doi: 10.1002/14651858.CD007156.pub3.
3
Oral Submucous Fibrosis: A Review of the Current Concepts in Management.
口腔黏膜下纤维化:治疗现状综述
Cureus. 2023 Oct 18;15(10):e47259. doi: 10.7759/cureus.47259. eCollection 2023 Oct.
4
Comparison of Intralesional Placentrex Versus Hyaluronidase and Dexamethasone Injection in the Symptomatic Management of Stage II Oral Submucous Fibrosis - a Prospective Study.病灶内注射胎盘组织液与透明质酸酶及地塞米松注射治疗II期口腔黏膜下纤维化症状的比较——一项前瞻性研究
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3530-3534. doi: 10.1007/s12070-023-04016-5. Epub 2023 Jul 4.
5
Oral Submucous Fibrosis and Scleroderma: A Review of the Etiopathogenesis, Clinicopathological Correlation, and Management Aspects.口腔黏膜下纤维化与硬皮病:病因发病机制、临床病理相关性及治疗方面的综述
Cureus. 2023 Aug 31;15(8):e44502. doi: 10.7759/cureus.44502. eCollection 2023 Aug.
6
Comparative Efficacy of Interventions for the Management of Oral Submucous Fibrosis: A Systematic Review and Network Meta-Analysis.口腔黏膜下纤维化管理干预措施的比较疗效:一项系统评价与网状Meta分析
J Pers Med. 2022 Aug 1;12(8):1272. doi: 10.3390/jpm12081272.
7
Curcumin relieves the arecoline-induced fibrosis of oral mucosal fibroblasts via inhibiting HIF-1α/TGF-β/CTGF signaling pathway: an study.姜黄素通过抑制HIF-1α/TGF-β/CTGF信号通路减轻槟榔碱诱导的口腔黏膜成纤维细胞纤维化:一项研究。
Toxicol Res (Camb). 2021 Jun 1;10(3):631-638. doi: 10.1093/toxres/tfab046. eCollection 2021 May.
8
Medicinal management of oral submucous fibrosis in the past decade- A systematic review.过去十年口腔黏膜下纤维化的药物治疗——一项系统综述
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):552-568. doi: 10.1016/j.jobcr.2020.08.004. Epub 2020 Aug 19.
9
Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.口腔黏膜下纤维性变:一种当代叙述性综述,提出了一种多专业协作的方法,以实现早期诊断和临床管理。
J Otolaryngol Head Neck Surg. 2020 Jan 8;49(1):3. doi: 10.1186/s40463-020-0399-7.
10
Buccal Mucosal Epithelial Cells Downregulate CTGF Expression in Buccal Submucosal Fibrosis Fibroblasts.颊黏膜上皮细胞下调颊黏膜下纤维化成纤维细胞中结缔组织生长因子的表达。
J Maxillofac Oral Surg. 2018 Jun;17(2):254-259. doi: 10.1007/s12663-017-1056-1. Epub 2017 Nov 17.